Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 46 (1), 205-16

A New Link to Mitochondrial Impairment in Tauopathies


A New Link to Mitochondrial Impairment in Tauopathies

Kathrin L Schulz et al. Mol Neurobiol.


Tauopathies like the "frontotemporal dementia with Parkinsonism linked to chromosome 17" (FTDP-17) are characterized by an aberrant accumulation of intracellular neurofibrillary tangles composed of hyperphosphorylated tau. For FTDP-17, a pathogenic tau mutation P301L was identified. Impaired mitochondrial function including disturbed dynamics such as fission and fusion are most likely major pathomechanisms of most neurodegenerative diseases. However, very little is known if tau itself affects mitochondrial function and dynamics. We addressed this question using SY5Y cells stably overexpressing wild-type (wt) and P301L mutant tau. P301L overexpression resulted in a substantial complex I deficit accompanied by decreased ATP levels and increased susceptibility to oxidative stress. This was paralleled by pronounced changes in mitochondrial morphology, decreased fusion and fission rates accompanied by reduced expression of several fission and fusion factors like OPA-1 or DRP-1. In contrast, overexpression of wt tau exhibits protective effects on mitochondrial function and dynamics including enhanced complex I activity. Our findings clearly link tau bidirectional to mitochondrial function and dynamics, identifying a novel aspect of the physiological role of tau and the pathomechanism of tauopathies.

Similar articles

See all similar articles

Cited by 34 PubMed Central articles

See all "Cited by" articles


    1. EMBO J. 2007 Oct 31;26(21):4546-54 - PubMed
    1. Mol Membr Biol. 2006 Nov-Dec;23(6):509-20 - PubMed
    1. N Engl J Med. 2002 Mar 14;346(11):811-20 - PubMed
    1. J Biol Chem. 2006 Apr 28;281(17):11856-63 - PubMed
    1. Neuropathol Appl Neurobiol. 1986 May-Jun;12(3):305-19 - PubMed

Publication types

LinkOut - more resources